SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChiRex (CHRX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dick Roy who wrote (37)8/20/1997 12:07:00 PM
From: Haseltine   of 130
 
CHRX IS HAVING A NICE RUN TODAY. DO YOU GET CHEMICAL AND ENGINEERING NEWS? THERE IS A BRIEF MENTION OF SOME NEW TECHNOLOGY THAT CHIREX HAS LICENSED FROM HARVARD IN THE AUGUST 18 ISSUE. THE ARTICLE REFERS TO A SCIENTIFIC PAPER BY HARVARD'S PROF. ERIC N. JACOBSEN IN SCIENCE MAGAZINE. FROM WHAT I CAN UNDERSTAND HE HAS DEVELOPED A WAY OF RESOLVING EPOXIDES CHEAPLY. JACOBSEN IS QUOTED IN CHEM AND ENG NEWS AS SAYING:

"IT APPEARS THAT THIS REACTION IS REALLY GOING TO HAVE AN ENORMOUS IMPACT ON THE INDUSTRIAL SYNTHESIS OF CHIRAL BUILDING BLOCKS...CHIREX HAS ALREADY SCALED UP THE PROPYLENE OXIDE KINETIC RESOLUTION, AND THEY HAVE BIG PLANS FOR EPICHLOROHYDRIN AND BUTADIENE MONOEPOXIDE."

WHAT DO YOU THINK?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext